Patients treated with TXA had a significantly lower blood loss and lower rates of allogeneic blood transfusion than the control group. Further investigation is required regarding the safety of TXA before it can be generalized in the use of idiopathic scoliosis surgery.

Highlights Primary hepatic neuroendocrine tumors (NETs) are extremely rare. A centrally located hepatic NET may present a challenging clinical situation. Surgical resection remains the treatment of choice and plays a potentially curative role.